These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 991467

  • 1. On the pathogenesis of Bartter's syndrome: report of studies in a patient with this disorder.
    Norby L, Mark AL, Kaloyanides GJ.
    Clin Nephrol; 1976 Sep; 6(3):404-13. PubMed ID: 991467
    [Abstract] [Full Text] [Related]

  • 2. [Plasma-aldosterone and renin activity in Bartter's syndrome (author's transl)].
    Rössler R.
    Dtsch Med Wochenschr; 1975 Nov 21; 100(47):2443-8. PubMed ID: 171132
    [Abstract] [Full Text] [Related]

  • 3. Bartter's syndrome. New insights into pathogenesis and treatment.
    Solomon RJ, Brown RS.
    Am J Med; 1975 Oct 21; 59(4):575-83. PubMed ID: 1166859
    [Abstract] [Full Text] [Related]

  • 4. Aldosterone and other mineralocorticoids in Bartter's syndrome.
    Saruta T, Fujimaki M, Senba S, Saito I, Konishi K.
    J Lab Clin Med; 1984 Jun 21; 103(6):848-53. PubMed ID: 6373989
    [Abstract] [Full Text] [Related]

  • 5. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
    Yamamoto T, Doi K, Ogihara T, Ichihara K, Hata T, Kumahara Y.
    Prog Biochem Pharmacol; 1976 Jun 21; 12():174-89. PubMed ID: 1019163
    [Abstract] [Full Text] [Related]

  • 6. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium.
    Casals-Stenzel J, Tree M, Brown JJ, Fraser R, Lever AF, Millar JA, Morton JJ, Robertson JI, Reid JL, Hamilton C.
    J Hypertens; 1983 Jun 21; 1(1):27-35. PubMed ID: 6397510
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Role of prostaglandins in the pathogenesis of Bartter's syndrome.
    Fichman MP, Telfer N, Zia P, Speckart P, Golub M, Rude R.
    Am J Med; 1976 May 31; 60(6):785-97. PubMed ID: 798488
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs.
    Kjolby MJ, Kompanowska-Jezierska E, Wamberg S, Bie P.
    Acta Physiol Scand; 2005 Jul 31; 184(3):225-34. PubMed ID: 15954990
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical findings, pathogenesis and treatment of Bartter's syndrome (author's transl)].
    Ploier R, Tulzer W.
    Wien Med Wochenschr; 1981 Jul 31; 131(11):287-93. PubMed ID: 7020264
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Study of the effects of cicletanine on the renin-angiotensin-aldosterone system.
    Bippi H, Guinot P.
    Drugs Exp Clin Res; 1988 Jul 31; 14(2-3):215-20. PubMed ID: 3046885
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.